Rivertek Medical Systems

Rivertek Medical Systems was a medical technology company focused on developing innovative interventional cardiology and radiology devices. The company's primary product, the RiverCross support catheter, was designed to assist clinicians in crossing complex chronic total occlusions (CTO) in the coronary and peripheral vasculature. By providing a high level of support and steerability, the device aimed to increase the success rate of minimally invasive vascular procedures. Headquartered in Maple Grove, Minnesota, the company was backed by prominent venture capital firms. In 2011, Rivertek was acquired by Teleflex Incorporated to enhance its portfolio of vascular access and interventional products. The technology has since been integrated into Teleflex's broader interventional cardiology business unit.